Health and economic effects on patients with type 2 diabetes mellitus in the long run: predictions for the Chilean population

Abstract

Background Diabetes is associated to a high financial and disease burden, explaining a large proportion of expenditure of the health system in one year. The purpose of this study was to estimate long-term costs and health outcomes of recently diagnosed patients with type 2 diabetes in Chile. Methods Cost and consequence study based on mathematical discrete event simulation (DES) model. We modelled expected costs (USD) and quality-adjusted life-years (QALYs) from diagnosis to death (or the age of 95) of a hypothetical cohort of 100,000 incident cases, simulated based on the Chilean National Health Survey 2018. The incidence of twelve complications was estimated assuming the hazard functions provided by the United Kingdom Prospective Diabetes Study. We explore heterogeneity across patients based on their baseline risk covariates and their impact on costs and QALYs. Results The expected cost and QALY of a recently diagnosed type 2 diabetes patient in Chile were USD 8660 and 12.44 QALYs. Both costs and QALYs were independently determined by baseline risk and the patient's life expectancy from the diagnosis. Length of life since diagnosis showed the major impact on costs (5.2% increase for every additional year). Myocardial infarction was the most frequent complication (47.4%) and the most frequent cause of death. Conclusion Diabetes type 2 determines a significant expenditure of the health system and substantial health losses. Although the control of cardiovascular risk factors and the metabolic control of the disease, both have an important impact on costs and outcomes, the main impact is achieved by postponing the age of onset of the disease.

Impact of a Discontinuous Training Program on Sedentary Behavior in Italian Type 2 Diabetes Older Patients: The Results of the TRIPL-A Randomized Controlled Trial

“…T2D affects multiple organs and systems, such as the heart, brain, kidneys, and nerves, and presents a growing health problem [36]. Consequently, T2D significantly impacts the health system [8]. One way that problem could be met is by applying an education program to modify urbanization-related lifestyle habits.…”

“…One way that problem could be met is by applying an education program to modify urbanization-related lifestyle habits. Professional health education, such as the self-management of T2D, in terms of diet and PA could help change unhealthy lifestyle habits [8]. For example, it has been seen that ERSs could be an efficient model for promoting PA in primary care settings [19].…”

“…Type 2 diabetes (T2D) is a growing global health problem [7]. Besides the question of the individual quality of life that this disease influences, the impact of T2D on the financial burden on healthcare systems is significant [8]. A recent meta-analysis demonstrated that exercise intervention improves inflammatory, metabolic, lipid markers, and insulin resistance in older adults with T2D [9].…”

Future burden of non-communicable diseases attributable to overweight in Chile: a multistate life table modeling study

“…The most significant impact on morbidity of overweight seems to be due to type 2 diabetes, which prevalence in Chile reaches 12.3% [ 12 ]. This would have a great impact on Chilean burden considering its high treatment costs [ 27 ] and increasing prevalence in Chile [ 5 ]. In this sense, it seems important to consider the consequence of overweight as an objective within the programs that seek to control and improve the levels of obesity in Chile.…”

The influence of telemedicine in primary healthcare on diabetes mellitus control and treatment adherence in Riyadh region

“…Diabetes mellitus (DM) is one of the diseases with alarmingly high prevalence rates in Saudi Arabia, with an 18.7 % prevalence ( IDF, 2022 ). Diabetes is a chronic metabolic condition that has major economic consequences ( Espinoza et al, 2022 ). The illness affects millions of people worldwide and is associated with a wide spectrum of macrovascular and microvascular problems that significantly contribute to the cardiovascular burden of diabetes mellitus, resulting in higher morbidity and mortality rates ( Dal Canto et al, 2019 ).…”